Medirom Healthcare Technologies (MRM) Cash & Current Investments (2019 - 2025)

Medirom Healthcare Technologies' Cash & Current Investments history runs 7 years deep, the most recent figure standing at $268282.2 for Q2 2025.

• In Q2 2025, Cash & Current Investments fell 60.73% year-over-year to $268282.2; the TTM figure through Jun 2025 stood at $268282.2 (down 60.73% YoY), while the FY2024 annual figure was $2.2 million, up 136.24% from the prior year.
• Cash & Current Investments was $268282.2 for Q2 2025 at Medirom Healthcare Technologies, down from $2.2 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $13.2 million in Q2 2021 to a low of $233356.0 in Q4 2021.
• Historically, Cash & Current Investments has averaged $3.4 million across 5 years, with a median of $2.8 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Cash & Current Investments surged 1104.56% in 2022, then slumped 84.54% in 2024.
• A 5-year view of Cash & Current Investments shows it stood at $233356.0 in 2021, then surged by 1104.56% to $2.8 million in 2022, then jumped by 52.1% to $4.3 million in 2023, then slumped by 48.37% to $2.2 million in 2024, then plunged by 87.85% to $268282.2 in 2025.
• The last three Cash & Current Investments figures came in at $268282.2 (Q2 2025), $2.2 million (Q4 2024), and $683162.4 (Q2 2024), per Business Quant data.